Horizon Therapeutics Public Ltd Co
HZNPDelisted Oct 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492426
Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2021
Institutional positions in Horizon Therapeutics Public Ltd Co as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 516
- No complete 13F data for Q4 2020
- Shares held
- 200.2M
- No complete 13F data for Q4 2020
- Total value
- $18.4B
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting HZNP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $116 |
| Q1 2026 | 1 | $116 |
| Q4 2025 | 1 | $116 |
| Q3 2025 | 1 | $116 |
| Q2 2025 | 1 | $116 |
| Q1 2025 | 1 | $116 |
| Q4 2024 | 1 | $116 |
| Q3 2024 | 1 | $116 |
| Q2 2024 | 2 | $3.95K |
| Q1 2024 | 1 | $116 |
| Q4 2023 | 6 | $49.4K |
| Q3 2023 | 483 | $24.8B |
| Q2 2023 | 516 | $21.7B |
| Q1 2023 | 552 | $22.5B |
| Q4 2022 | 611 | $23.8B |
| Q3 2022 | 528 | $13.0B |
| Q2 2022 | 615 | $16.5B |
| Q1 2022 | 618 | $21.8B |
| Q4 2021 | 609 | $22.0B |
| Q3 2021 | 571 | $22.2B |
| Q2 2021 | 527 | $18.9B |
| Q1 2021 | 516 | $18.4B |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Horizon Therapeutics Public Ltd Co.
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameriprise Financial Inc | 2,730,327 | $251.8M | 0.08% | – | – |
| Allianz Asset Management GmbH | 2,897,538 | $266.7M | 0.27% | – | – |
| OrbiMed Advisors LLC | 3,144,355 | $289.4M | 2.73% | – | – |
| Voya Investment Management LLC | 3,187,115 | $293.3M | 0.59% | – | – |
| Nuveen Asset Management, LLC | 3,733,763 | $343.7M | 0.11% | – | – |
| Bank of New York Mellon Corp | 3,931,741 | $361.9M | 0.07% | – | – |
| William Blair Investment Management, LLC | 4,149,195 | $381.9M | 1.24% | – | – |
| State Street Corp | 4,367,633 | $402.0M | 0.02% | – | – |
| Renaissance Technologies LLC | 5,209,963 | $479.5M | 0.60% | – | – |
| JPMorgan Chase & Co | 5,635,181 | $518.7M | 0.07% | – | – |
| Janus Henderson Group PLC | 7,597,157 | $699.2M | 0.32% | – | – |
| Paulson & Co. Inc. | 7,991,440 | $735.5M | 16.90% | – | – |
| Avoro Capital Advisors LLC | 9,000,000 | $828.4M | 14.31% | – | – |
| FMR LLC | 13,939,994 | $1.28B | 0.11% | – | – |
| BlackRock Inc. | 15,377,169 | $1.42B | 0.04% | – | – |
| Vanguard Group Inc | 20,504,397 | $1.89B | 0.05% | – | – |